752 related articles for article (PubMed ID: 29130619)
1. A feasibility study of transaxillary TAVI with the lotus valve.
Doshi SN; George S; Kwok CS; Mechery A; Mamas M; Ludman PF; Townend JN; Bhabra M
Catheter Cardiovasc Interv; 2018 Sep; 92(3):542-549. PubMed ID: 29130619
[TBL] [Abstract][Full Text] [Related]
2. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
[TBL] [Abstract][Full Text] [Related]
3. Direct percutaneous transaxillary implantation of a novel self-expandable transcatheter heart valve for aortic stenosis.
Deuschl F; Schofer N; Seiffert M; Hakmi S; Mizote I; Schaefer A; Schirmer J; Reichenspurner H; Blankenberg S; Conradi L; Schäfer U
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1167-1174. PubMed ID: 28296065
[TBL] [Abstract][Full Text] [Related]
4. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience.
Taramasso M; Denegri A; Kuwata S; Rickli H; Haager PK; Sütsch G; Rodriguez Cetina Biefer H; Kottwitz J; Nietlispach F; Maisano F
Catheter Cardiovasc Interv; 2018 Feb; 91(3):533-539. PubMed ID: 28500739
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A
Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127
[TBL] [Abstract][Full Text] [Related]
7. Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes.
Kallinikou Z; Berger A; Ruchat P; Khatchatourov G; Fleisch I; Korkodelovic B; Henchoz E; Marti RA; Cook S; Togni M; Goy JJ
Arch Cardiovasc Dis; 2017; 110(6-7):389-394. PubMed ID: 28433509
[TBL] [Abstract][Full Text] [Related]
8. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
9. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of the percutaneous transaxillary access for transcatheter aortic valve implantation using various transcatheter heart valves in 100 consecutive patients.
Schäfer U; Deuschl F; Schofer N; Frerker C; Schmidt T; Kuck KH; Kreidel F; Schirmer J; Mizote I; Reichenspurner H; Blankenberg S; Treede H; Conradi L
Int J Cardiol; 2017 Apr; 232():247-254. PubMed ID: 28118931
[TBL] [Abstract][Full Text] [Related]
11. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.
Conzelmann LO; Würth A; Balthasar V; Neuber C; Tzamalis P; Gonska BD; Schmitt C; Mehlhorn U; Schymik G
Catheter Cardiovasc Interv; 2020 Jan; 95(1):E21-E29. PubMed ID: 31115146
[TBL] [Abstract][Full Text] [Related]
13. Transubclavian approach: A competitive access for transcatheter aortic valve implantation as compared to transfemoral.
Amat-Santos IJ; Rojas P; Gutiérrez H; Vera S; Castrodeza J; Tobar J; Goncalves-Ramirez LR; Carrasco M; Catala P; San Román JA
Catheter Cardiovasc Interv; 2018 Nov; 92(5):935-944. PubMed ID: 29314570
[TBL] [Abstract][Full Text] [Related]
14. Transaxillary versus transaortic approach for transcatheter aortic valve implantation with CoreValve Revalving System: insights from multicenter experience.
Fiorina C; Bruschi G; Testa L; DE Carlo M; DE Marco F; Coletti G; Bonardelli S; Adamo M; Curello S; Scioti G; Panisi P; Bedogni F; Petronio AS; Ettori F
J Cardiovasc Surg (Torino); 2017 Oct; 58(5):747-754. PubMed ID: 27701369
[TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness of the transsubclavian approach for transcatheter aortic valve implantation with the 14-F CoreValve Evolut R device.
Anselmi A; Tomasi J; Giardinelli F; Bedossa M; Rosier S; Verhoye JP
J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):664-668. PubMed ID: 30299409
[TBL] [Abstract][Full Text] [Related]
16. Alternative access for transcatheter aortic valve replacement in older adults: A collaborative study from France and United States.
Damluji AA; Murman M; Byun S; Moscucci M; Resar JR; Hasan RK; Alfonso CE; Carrillo RG; Williams DB; Kwon CC; Cho PW; Dijos M; Peltan J; Heldman AW; Cohen MG; Leroux L
Catheter Cardiovasc Interv; 2018 Nov; 92(6):1182-1193. PubMed ID: 29968273
[TBL] [Abstract][Full Text] [Related]
17. Transfemoral transcatheter aortic valve replacement in the presence of a mitral prosthesis.
Toutouzas K; Drakopoulou M; Latsios G; Synetos A; Stathogiannis K; Soulaidopoulos S; Oikonomou G; Trantalis G; Papanikolaou A; Aggeli C; Vavuranakis M; Mastrokostopoulos A; Katsimaglis G; Voudris V; Dardas P; Tousoulis D
J Cardiovasc Med (Hagerstown); 2019 Dec; 20(12):825-830. PubMed ID: 31592849
[TBL] [Abstract][Full Text] [Related]
18. Facilitating right-sided axillary artery access for transcatheter aortic valve replacement using the Edwards Sapien 3 and ultra valves: Technical considerations.
Rajkumar CA; Cook C; Shalhoub J; Chukwuemeka A; Jaffer U; Hadjiloizou N; Sen S; Ruparelia N; Mikhail G; Malik IS
Catheter Cardiovasc Interv; 2020 Dec; 96(7):E747-E754. PubMed ID: 31631520
[TBL] [Abstract][Full Text] [Related]
19. Axillary Transcatheter Aortic Valve Replacement in Patients With Peripheral Vascular Disease.
Hysi I; Gommeaux A; Pécheux M; Hochart P; Hannebicque G; Pâris M; Manchuelle A; Fabre O
Semin Thorac Cardiovasc Surg; 2019; 31(2):175-180. PubMed ID: 30291887
[TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach.
Drafts BC; Choi CH; Sangal K; Cammarata MW; Applegate RJ; Gandhi SK; Kincaid EH; Kon N; Zhao DX
Catheter Cardiovasc Interv; 2018 Jun; 91(7):1354-1362. PubMed ID: 29024382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
